Literature DB >> 24970694

CXCR7 and CXCR4 Expressions in Infiltrative Astrocytomas and Their Interactions with HIF1α Expression and IDH1 Mutation.

Andre Macedo Bianco1, Miyuki Uno, Sueli Mieko Oba-Shinjo, Carlos Afonso Clara, Thais Fernanda de Almeida Galatro, Sergio Rosemberg, Manoel Jacobsen Teixeira, Suely Kazue Nagahashi Marie.   

Abstract

The CXCR7, a new receptor for CXCL12 with higher affinity than CXCR4 has raised key issues on glioma cell migration. The aim of this study is to investigate the CXCR7 mRNA expression in diffuse astrocytomas tissues and to evaluate its interactions with CXCR4 and HIF1α expression and IDH1 mutation. CXCR7, CXCR4 and HIF1α mRNA expression were evaluated in 129 frozen samples of astrocytomas. IDH1 mutation status was analyzed with gene expressions, matched with clinicopathological parameters and overall survival time. Protein expression was analyzed by immunohistochemistry in different grades of astrocytoma and in glioma cell line (U87MG) by confocal microscopy. There was significant difference in the expression levels of the genes studied between astrocytomas and non-neoplasic (NN) controls (p < 0.001). AGII showed no significant correlation between CXCR7/HIF1α (p = 0.548); there was significant correlation between CXCR7/CXCR4 (p = 0.042) and CXCR7/IDH1 (p = 0.008). GBM showed significant correlations between CXCR7/CXCR4 (p = 0.002), CXCR7/IDH1 (p < 0.001) and CXCR7/HIF1α (p = 0.008). HIF1α overexpression was associated with higher expressions of CXCR7 (p = 0.01) and CXCR4 (p < 0.0001), while IDH1 mutation was associated with lower CXCR7 (p = 0.009) and CXCR4 (p = 0.0005) mRNA expressions. Protein expression increased with malignancy and in U87MG cell line was mainly localized in the cellular membrane. CXCR7 was overexpressed in astrocytoma and correlates with CXCR4 and IDH1 in AGII and CXCR4, IDH1 and HIF1α in GBM. Overexpression HIF1α was related with higher expressions of CXCR7 and CXCR4, otherwise IDH1 mutation related with lower expression of both genes. No association between CXCR7 and CXCR4 expression and survival data was related.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24970694     DOI: 10.1007/s12253-014-9813-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  59 in total

1.  The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.

Authors:  Karl Balabanian; Bernard Lagane; Simona Infantino; Ken Y C Chow; Julie Harriague; Barbara Moepps; Fernando Arenzana-Seisdedos; Marcus Thelen; Françoise Bachelerie
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

2.  Role of chemokine receptor CXCR7 in bladder cancer progression.

Authors:  Mingang Hao; Jianghua Zheng; Kailin Hou; Jinglong Wang; Xiaosong Chen; Xiaojiong Lu; Junjie Bo; Chen Xu; Kunwei Shen; Jianhua Wang
Journal:  Biochem Pharmacol       Date:  2012-04-13       Impact factor: 5.858

Review 3.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

4.  Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.

Authors:  Florian Gebauer; Michael Tachezy; Katharina Effenberger; Katharina von Loga; Hilke Zander; Alexander Marx; Jussuf T Kaifi; Guido Sauter; Jakob R Izbicki; Maximilian Bockhorn
Journal:  J Surg Oncol       Date:  2011-04-25       Impact factor: 3.454

5.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Authors:  David Zagzag; Yevgeniy Lukyanov; Li Lan; M Aktar Ali; Mine Esencay; Olga Mendez; Herman Yee; Evelyn B Voura; Elizabeth W Newcomb
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

6.  Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.

Authors:  Ke Zheng; Hong-Yuan Li; Xin-Liang Su; Xiao-Yi Wang; Tian Tian; Fan Li; Guo-Sheng Ren
Journal:  J Exp Clin Cancer Res       Date:  2010-04-11

7.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.

Authors:  Zhenhua Miao; Kathryn E Luker; Bretton C Summers; Rob Berahovich; Mahaveer S Bhojani; Alnawaz Rehemtulla; Celina G Kleer; Jeffrey J Essner; Aidas Nasevicius; Gary D Luker; Maureen C Howard; Thomas J Schall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

8.  Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

Authors:  Evemie Schutyser; Yingjun Su; Yingchun Yu; Mieke Gouwy; Snjezana Zaja-Milatovic; Jo Van Damme; Ann Richmond
Journal:  Eur Cytokine Netw       Date:  2007-06-26       Impact factor: 2.737

9.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

10.  CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.

Authors:  M Schrevel; R Karim; N T ter Haar; S H van der Burg; J B M Z Trimbos; G J Fleuren; A Gorter; E S Jordanova
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

View more
  6 in total

1.  Serum amyloid A1 is upregulated in human glioblastoma.

Authors:  Franciele Hinterholz Knebel; Miyuki Uno; Thais F Galatro; Luziane Potrich Bellé; Sueli Mieko Oba-Shinjo; Suely Kazue N Marie; Ana Campa
Journal:  J Neurooncol       Date:  2017-03-11       Impact factor: 4.130

2.  Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.

Authors:  Franziska Lange; Daniel Kaemmerer; Julianne Behnke-Mursch; Wolfgang Brück; Stefan Schulz; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-25       Impact factor: 4.553

Review 3.  The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.

Authors:  Magdalena Groblewska; Ala Litman-Zawadzka; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

4.  Role of CXCR7 as a Common Predictor for Prognosis in Solid Tumors: a Meta-Analysis.

Authors:  Qitai Zhao; Penghua Zhang; Guohui Qin; Feifei Ren; Yujia Zheng; Yamin Qiao; Ting Sun; Yi Zhang
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

5.  BMSC-Exosomes Carry Mutant HIF-1α for Improving Angiogenesis and Osteogenesis in Critical-Sized Calvarial Defects.

Authors:  Chenting Ying; Rui Wang; Zhenlin Wang; Jie Tao; Wenjing Yin; Jieyuan Zhang; Chengqing Yi; Xin Qi; Dan Han
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

6.  CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather.

Authors:  Sarah M Jacobs; Pieter Wesseling; Bart de Keizer; Nelleke Tolboom; F F Tessa Ververs; Gerard C Krijger; Bart A Westerman; Tom J Snijders; Pierre A Robe; Anja G van der Kolk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-07       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.